Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Sommerfelt, Randi M ^a   Feuerherm, Astrid J ^a   Skuland, Trine ^a   Johansen, Berit ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOSOLIC PHOSPHOLIPASE A2; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; SECRETORY PHOSPHOLIPASE A2; SERINE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; DIACYLGLYCEROL; FSL-1 LIPOPROTEIN, SYNTHETIC; IL6 PROTEIN, HUMAN; OLIGOPEPTIDE; PHOSPHOLIPASE A2 GROUP IV; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TLR6 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN SECRETION; SYNOVIOCYTE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM; TUMOR CELL LINE;

ARACHIDONIC ACID; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DIGLYCERIDES; DINOPROSTONE; FIBROBLASTS; GENE EXPRESSION REGULATION; GROUP IV PHOSPHOLIPASES A2; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; OLIGOPEPTIDES; PHOSPHOLIPASE A2 INHIBITORS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANSCRIPTION, GENETIC;

EID: 84929484755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119088     Document Type: Article

References (72)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365: 2205-2219. doi: 10.1056/NEJMra1004965 PMID: 22150039
2. Van Der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 2000; 43: 593-598. PMID: 10728753
3. Buckley CD. Why does chronic inflammation persist: An unexpected role for fibroblasts. Immunol Lett. 2011; 138: 12-14. doi: 10.1016/j.imlet.2011.02.010 PMID: 21333681
4. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233: 233-255. doi: 10.1111/j.0105-2896.2009.00859.x PMID: 20193003
5. Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008; 14: 461-469. doi: 10.1016/j.molmed.2008.08.005 PMID: 18774339
6. Kalinski P. Regulation of Immune Responses by Prostaglandin E2. J Immunol. 2012; 188: 21-28. doi: 10.4049/jimmunol.1101029 PMID: 22187483
7. Husby G, Bankhurst AD, Williams RC. Immunohistochemical localization of prostaglandin E in rheumatoid synovial tissues. Arthritis Rheum. 1977; 20: 785-791. PMID: 324481
8. Murakami M. Lipid Mediators in Life Science. Exp Anim. 2011; 60: 7-20. PMID: 21325748
9. Dennis EA, Cao J, Hsu Y, Magrioti V, Kokotos G. Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention. Chem Rev. 2011; 111: 6130-6185. doi: 10.1021/cr200085w PMID: 21910409
10. Sundler R, Winstedt D, Wijkander J. Acyl-chain selectivity of the 85 kDa phospholipase A2 and of the release process in intact macrophages. Biochem J. 1994; 15: 455-458.
11. Singer AG, Ghomashchi F, Le Calvez C, Bollinger J, Bezzine S, Rouault M, et al. Interfacial Kinetic and Binding Properties of the Complete Set of Human and Mouse Groups I, II, V, X, and XII Secreted Phospholipases A2. J Biol Chem. 2002; 277: 48535-48549. PMID: 12359733
12. Lio YC, Dennis EA. Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2. Biochim Biophys Acta. 1998; 1392: 320-332. PMID: 9630702
13. Uozumi N, Kume K, Nagase T, Nakatani N, Ishii S, Tashiro F, et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 1997; 390: 618-622. PMID: 9403692
14. Nagase T, Uozumi N, Ishii S, Kita Y, Yamamoto H, Ohga E, et al. A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis. Nat Med. 2002; 8: 480-484. PMID: 11984592
15. Nagase T, Uozumi N, Ishii S, Kume K, Izumi T, Ouchi Y, et al. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol. 2000; 1: 42-46. PMID: 10881173
16. Hegen M, Sun L, Uozumi N, Kume K, Goad ME, Nickerson-Nutter CL, et al. Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J Exp Med. 2003; 197: 1297-1302. PMID: 12743172
17. Malaviya R, Ansell J, Hall L, Fahmy M, Argentieri RL, Olini JGC, et al. Targeting cytosolic phospholipase A2 by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice. Eur J Pharmacol. 2006; 539: 195-204. PMID: 16712837
18. Tai N, Kuwabara K, Kobayashi M, Yamada K, Ono T, Seno K, et al. Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model. Inflamm Res. 2010; 59: 53-62. doi: 10.1007/s00011-009-0069-8 PMID: 19655230
19. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11: 373-384. doi: 10.1038/ni.1863 PMID: 20404851
20. Goh FG, Midwood KS. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology. 2012; 51: 7-23. doi: 10.1093/rheumatology/ker257 PMID: 21984766
21. Huang Q-Q, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM, Tak PP, et al. Heat Shock Protein 96 Is Elevated in Rheumatoid Arthritis and Activates Macrophages Primarily via TLR2 Signaling. J Immunol. 2009; 182: 4965-4973. doi: 10.4049/jimmunol.0801563 PMID: 19342676
22. Schett G, Redlich K, Xu Q, Bizan P, Gröger M, Tohidast-Akrad M, et al. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs. J Clin Invest. 1998; 102: 302-311. PMID: 9664071
23. Tamaki Y, Takakubo Y, Hirayama T, Konttinen YT, Goodman SB, Yamakawa M, et al. Expression of Toll-like Receptors and Their Signaling Pathways in Rheumatoid Synovitis. J Rheumatol. 2011; 38: 810-820. doi: 10.3899/jrheum.100732 PMID: 21324962
24. Seibl R, Birchler T, Loeliger S, Hossle J, Gay R, Saurenmann T, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003; 162: 1221-1227. PMID: 12651614
25. Lindner SC, Köhl U, Maier TJ, Steinhilber D, Sorg BL. TLR2 ligands augment cPLA2α activity and lead to enhanced leukotriene release in human monocytes. J Leukoc Biol. 2009; 86: 389-399. doi: 10.1189/jlb.1008591 PMID: 19401382
26. Ruipérez V, Astudillo AM, Balboa MA, Balsinde J. Coordinate Regulation of TLR-Mediated Arachidonic Acid Mobilization in Macrophages by Group IVA and Group V Phospholipase A2s. J Immunol. 2009; 182: 3877-3883. doi: 10.4049/jimmunol.0804003 PMID: 19265167
27. Anthonsen MW, Andersen S, Solhaug A, Johansen B. Atypical λ/ιPKC Conveys 5-Lipoxygenase/Leukotriene B4-mediated Cross-talk between Phospholipase A2s Regulating NF-κB Activation in Response to Tumor Necrosis Factor-α and Interleukin-1β. J Biol Chem. 2001; 276: 35344-35351. PMID: 11445585
28. Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009; 37: e45. doi: 10.1093/nar/gkp045 PMID: 19237396
29. Masuda S, Murakami M, Komiyama K, Ishihara M, Ishikawa Y, Ishii T, et al. Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells. FEBS J. 2005; 272: 655-672. PMID: 15670148
30. Chi PL, Luo SF, Hsieh HL, Lee IT, Hsiao LD, Chen YL, et al. Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2011; 63: 2905-2917. doi: 10.1002/art.30504 PMID: 21702012
31. Johansen B, Rakkestad K, Balboa MA, Dennis EA. Expression of cytosolic and secreted forms of phospholipase A2 and cyclooxygenases in human placenta, fetal membranes, and chorionic cell lines. Prostaglandins Other Lipid Mediat. 2000; 60: 119-125. PMID: 10751642
32. Ohto T, Uozumi N, Hirabayashi T, Shimizu T. Identification of Novel Cytosolic Phospholipase A2s, Murine cPLA2δ, ε, and ζ, Which Form a Gene Cluster with cPLA2β. J Biol Chem. 2005; 280: 24576-24583. PMID: 15866882
33. Varastehpour A, Radaelli T, Minium J, Ortega H, Herrera E, Catalano P, et al. Activation of Phospholipase A2 Is Associated with Generation of Placental Lipid Signals and Fetal Obesity. J Clin Endocrinol Metab. 2006; 91: 248-255. PMID: 16249288
34. Mosher AA, Rainey KJ, Riley B, Levinson HS, Vinturache AE, Wood SL, et al. Regulation of sPLA2-IID in Human Decidua: Insights Into the Complexity of the Prostaglandin Pathway in Labor. Reprod Sci. 2014.
35. Kikawada E, Bonventre JV, Arm JP. Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2α activation. Blood. 2007; 110: 561-567. PMID: 17369491
36. Kokotos G, Feuerherm A, Barbayianni E, Shah I, Sæther M, Magrioti V, et al. Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones In Vitro, Ex Vivo, and In Vivo. J Med Chem. 2014; 57: 7523-7535. doi: 10.1021/jm500192s PMID: 25152071
37. Ludwig J, Bovens S, Brauch C, Elfringhoff AS, Lehr M. Design and Synthesis of 1-Indol-1-yl-propan-2- ones as Inhibitors of Human Cytosolic Phospholipase A2α. J Med Chem. 2006; 49: 2611-2620. PMID: 16610804
38. Huwiler A, Feuerherm AJ, Sakem B, Pastukhov O, Filipenko I, Nguyen T, et al. The ω3-polyunsaturated fatty acid derivatives AVX001 and AVX002 directly inhibit cytosolic phospholipase A2 and suppress prostaglandin E2 formation in mesangial cells. Br J Pharmacol. 2012; 168: 1691-1701.
39. Sommerfelt RM, Feuerherm AJ, Jones K, Johansen B. Cytosolic phospholipase A2 regulates TNF-induced production of joint destructive effectors in synoviocytes PLOS One. 2013; 8: e83555. doi: 10.1371/journal.pone.0083555 PMID: 24349530
40. Street IP, Lin HK, Laliberté F, Ghomashchi F, Wang Z, Perrier H, et al. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry. 1993; 32: 5935-5940. PMID: 8018213
41. Antonopoulou G, Barbayianni E, Magrioti V, Cotton N, Stephens D, Constantinou-Kokotou V, et al. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A2 enzymes. Bioorg Med Chem. 2008; 16: 10257-10269. doi: 10.1016/j.bmc.2008.10.046 PMID: 18993078
42. Snyder DW, Bach NJ, Dillard RD, Draheim SE, Carlson DG, Fox N, et al. Pharmacology of LY315920/ S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI. J Pharmacol Exp Ther. 1999; 288: 1117-1124. PMID: 10027849
43. Anthonsen MW, Solhaug A, Johansen B. Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation. J Biol Chem. 2001; 276: 30527-30536. PMID: 11390371
44. Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, Giddins G, et al. The Toll-Like Receptor Adaptor Proteins MyD88 and Mal/TIRAP Contribute to the Inflammatory and Destructive Processes in a Human Model of Rheumatoid Arthritis. Am J Pathol. 2007; 170: 518-525. PMID: 17255320
45. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum. 2003; 48: 642-650. PMID: 12632416
46. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T, et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature. 2009; 458: 1185-1190. doi: 10.1038/nature07924 PMID: 19322177
47. Dieter P, Kolada A, Kamionka S, Schadow A, Kaszkin M. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: Regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. Cell Signal. 2002; 14: 199-204. PMID: 11812647
48. Balsinde J, Balboa MA, Dennis EA. Functional coupling between secretory phospholipase A2 and cy-clooxygenase- 2 and its regulation by cytosolic group IV phospholipase A2. Proc Natl Acad Sci U S A. 1998; 95: 7951-7956. PMID: 9653121
49. Hulkower KI, Hope WC, Chen T, Anderson CM, Coffey JW, Morgan DW. Interleukin-1β stimulates cytosolic phospholipase A2 in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun. 1992; 184: 712-718. PMID: 1575744
50. Fraser H, Hislop C, Christie RM, Rick HL, Reidy CA, Chouinard ML, et al. Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE-/- Mice. J Cardiovasc Pharmacol. 2009; 53: 60-65 doi: 10.1097/FJC.0b013e318195bfbc PMID: 19129734
51. Murakami M, Taketomi Y, Miki Y, Sato H, Hirabayashi T, Yamamoto K. Recent progress in phospholipase A2 research: From cells to animals to humans. Prog Lipid Res. 2011; 50: 152-192. doi: 10.1016/j.plipres.2010.12.001 PMID: 21185866
52. Winstead MV, Balsinde J, Dennis EA. Calcium-independent phospholipase A2: structure and function. Biochim Biophys Acta. 2000; 1488: 28-39. PMID: 11080674
53. Crofford LJ. Specific cyclooxygenase-2 inhibitors: what have we learned since they came into widespread clinical use? Curr Opin Rheumatol. 2002; 14: 225-230. PMID: 11981317
54. Philippe L, Alsaleh G, Suffert G, Meyer A, Georgel P, Sibilia J, et al. TLR2 Expression Is Regulated by MicroRNA miR-19 in Rheumatoid Fibroblast-like Synoviocytes. J Immunol. 2012; 188: 454-461. doi: 10.4049/jimmunol.1102348 PMID: 22105995
55. Choy E, Dayer JM. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology. 2010; 49: 15-24. doi: 10.1093/rheumatology/kep329 PMID: 19854855
56. Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, et al. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J Rheumatol. 1997; 24: 2069-2075. PMID: 9375862
57. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum. 1997; 40: 1096-1105. PMID: 9182920
58. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, et al. Interleukin 6 Is Required for the Development of Collagen-induced Arthritis. J Exp Med. 1998; 187: 461-468. PMID: 9463396
59. Sasai M, Saeki Y, Ohshima S, Nishioka K, Mima T, Tanaka T, et al. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 1999; 42: 1635-1643. PMID: 10446862
60. Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, et al. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum. 1998; 41: 2117-2121. PMID: 9870868
61. Levi M, Grange S, Frey N. Exposure-response relationship of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in a large population of patients with rheumatoid arthritis. J Clin Pharmacol. 2013; 53: 151-159. doi: 10.1177/0091270012437585 PMID: 23436260
62. Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006; 54: 2817-2829. PMID: 16947782
63. Inoue H, Takamori M, Shimoyama Y, Ishibashi H, Yamamoto S, Koshihara Y. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. Br J Pharmacol. 2002; 136: 287-295. PMID: 12010778
64. Honda T, Segi-Nishida E, Miyachi Y, Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/ EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med. 2006; 203: 325-335. PMID: 16446378
65. Kawashima M, Ogura N, Akutsu M, Ito K, Kondoh T. The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production. J Oral Pathol Med. 2013; 42: 499-506. doi: 10.1111/jop.12045 PMID: 23331485
66. Kunisch E, Jansen A, Kojima F, Löffler I, Kapoor M, Kawai S, et al. Prostaglandin E2 Differentially Modulates Proinflammatory/Prodestructive Effects of TNF-α on Synovial Fibroblasts via Specific E Prostanoid Receptors/cAMP. J Immunol. 2009; 183: 1328-1336. doi: 10.4049/jimmunol.0900801 PMID: 19542367
67. Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, et al. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum. 2001; 44: 31-40. PMID: 11212173
68. Hayashida K, Nank T, Girschick H, Yavuz S, Ochi T, Lipsky PE. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res. 2001; 3: 118-126. PMID: 11178119
69. Takahashi Y, Kasahara T, Sawai T, Rikimaru A, Mukaida N, Matsushima K, et al. The participation of IL-8 in the synovial lesions at an early stage of rheumatoid arthritis. Tohoku J Exp Med. 1999; 188: 75-87. PMID: 10494903
70. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, et al. Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol. 1994; 23: 2-7. PMID: 8108662
71. Pawliczak R, Logun C, Madara P, Lawrence M, Woszczek G, Ptasinska A, et al. Cytosolic phospholipase A2 group IVα but not secreted phospholipase A2 group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors ã 1 and 2 in human lung cells. J Biol Chem. 2004; 279: 48550-48561. PMID: 15331599
72. Raichel L, Berger S, Hadad N, Kachko L, Karter M, Szaingurten-Solodkin I, et al. Reduction of cPLA2a overexpression: An efficient anti-inflammatory therapy for collagen-induced arthritis. Eur J Immunol. 2008; 38: 2905-2915. doi: 10.1002/eji.200838545 PMID: 18825749